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Abstract: Deep infection is a serious and costly complication of total knee arthroplasty (TKA), which can increase patient 
morbidity and compromise functional outcome and satisfaction. Two-stage revision with an interval of parental antibiotics 
has been shown to be the most successful treatment in eradicating deep infection following TKA. 
We report a large series by a single surgeon with a highly specialized revision TKA referral practice. 
We identified 84 patients treated by a two-stage revision. We defined “successful two-stage revision” as negative 
intraoperative cultures and no further infection-related procedure. We defined “eradication of infection” on the basis of 
negative cultures and clinical diagnosis. 
After a mean follow up of 25 months, eradication of the infection was documented in 90.5% of the patients; some had 
undergone further surgical intervention after the index two-stage procedure. Successful two-stage revision (e.g. no I&D, 
fusion, amputation) was documented only in 63.5% of the patients. We also observed a trend between presence of 
resistant staphylococcus (MRSA) (p=0.05) as well as pre-revision surgical procedures (p=0.08) and a lower likelihood of 
successfully two-stage revision. 
Factors affecting the high failure rate included multiple surgeries prior to the two-stage revision done at our institution, 
and high prevalence of MRSA present among failed cases. 
The relatively high rate of failure to achieve a successful two-stage revision observed in our series may be attributed to the 
highly specialized referral practice. Thus increasing the prevalence of patients with previous failed attempts at infection 
eradication and delayed care as well as more fragile and immune compromised hosts. 
Keywords:  Total knee arthroplasty, periprosthetic joint infection, antibiotic impregnated cement, revision total knee 
arthroplasty, two-stage revision. 
INTRODUCTION 
  Total knee arthroplasty (TKA) has been shown to be a 
reliable and cost-effective procedure, with expected 
survivorship of around 95% at 15 years [1-4]. Deep infection 
is a serious and costly complication of TKA, which can 
increase patient morbidity and decrease patient outcome and 
satisfaction [5-7]. With an incidence of deep infection 
between 1%-2% of all primary TKA, and even higher in 
revision cases, thousands of deep infections of TKA occur 
annually in the United-States [5-8]. Different treatment 
options have been described in the literature; two-stage 
revision with an interval of parental antibiotic treatment has 
been shown to be the most successful treatment in 
eradicating deep infection following TKA [7, 9-11]. Success 
rate of two-stage revision protocols has been shown to be 
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around 90% and have become the standard of care in North 
America for chronically infected TKAs [9-15]. 
  A variety of techniques to manufacture the intra-articular 
antibiotic cement spacer have been reported in the literature and 
good results have been described for both pre-manufactured and 
intraoperatively fashioned cement spacers [16-18]. Currently 
both static and articulating cement spacers are used during the 
interstage period, each with its reported benefits and 
complications [15, 19-21]. Static and articulating spacers serve 
as sources of local antibiotic delivery and maintain soft tissue 
tensioning. Articulating spacers have been described to help 
patients maintain a specified range of motion during treatment, 
which has been shown to facilitate the second stage surgery and 
improve final range of motion. Reports of fractures of static 
spacers and dislocation of articulating ones have been described 
as complications of such treatments [15, 19-21]. 
  We report a large series of patients with deep infection 
following TKA managed by a single surgeon with a highly 
specialized revision TKA referral practice. The surgeon used a 
standardized surgical technique and treatment protocol, 
including an intraoperative fabricated static cement spacer Treatment Failure Among Infected Periprosthetic Patients  The Open Orthopaedics Journal, 2013, Volume 7    265 
constructed from a custom-made mold. Intraoperative 
fabrication of the cement spacer with a customized mold allows 
the surgeon the freedom of utilizing different cement types, 
choosing the added amount and type of antibiotics, and 
customizing the mold to the patient’s anatomy. We report the 
rate of infection eradication and successful two-stage revision, 
patient and infection characteristics that may predict failure or 
reinfection, and range of motion achieved after reimplantation. 
METHODS AND MATERIALS 
Study Design and Selection Criteria 
  This retrospective study was performed after institutional 
IRB approval from Brigham and Women’s Hospital 
investigation research board. The authors reviewed the charts of 
all patients who had undergone two-stage TKA revision at a 
single institution by a single surgeon between 2001-2011. All 
patients who had undergone a two-stage revision TKA for 
periprosthetic infection were included in the study. A diagnosis 
of periprosthetic joint infection (PJI) was based on joint fluid 
cultures, joint fluid cell count and differential, inflammatory 
markers, presence of a sinus tract, gross purulence observed at 
the time of surgery, and a positive histological exam for acute 
infection and inflamation in tissues obtained during surgery (the 
criteria used is aligned with current literature guidelines for 
diagnosis of PJI). 
  We identified 84 patients who were treated by a two-stage 
TKA revision for periprosthetic infection by the senior author 
(DE) with a single surgical technique, utilizing a static antibiotic 
spacer fabricated intraoperatively with a customized mold. 
Data Collection 
  Demographic and patient data were collected from hospital 
records for all patients including; BMI, age, gender and 
infection markers including C-reactive protein (CRP) and 
erythrocyte sedimentation rate (ESR). Infection data were 
evaluated by collecting both preoperative and intraoperative 
cultures, and synovial fluid cell counts and differential. 
Perioperative complications were recorded from the patients’ 
charts. The overall preoperative medical status of the patients 
was evaluated by the Charlson comorbidity index [22]. Failure 
to eradicate infection was diagnosed based on both positive 
cultures and clinical diagnosis. 
Surgical Technique 
  A median parapatellar approach was utilized in all cases, 
with a joint fluid aspiration performed prior to the arthrotomy, 
followed by an extensive synovectomy and explantation of all 
implants. Perioperative antibiotics were held until the joint 
aspiration was completed. Endosteal membrane was removed 
from both the femoral and tibial medullary canals and was sent 
for culture and histology. 
  After verification that entire remaining cement was 
debrided, a ball tip guide wire was placed down the tibial canal. 
Sequential flexible reamers were used to ream the tibial and 
femoral canals until sufficient endosteal chatter was created to 
remove all retained debris and create a bleeding bony surface. 
At that point we used our custom-made canal mold seizers (Fig. 
1) to measure both the tibial and femoral canal diameters. Then 
irrigation of both canals was carried out using a pulse lavage 
device; first three liters of saline solution were used in each   
 
 
Fig. (1). Tibial canal sizing with the costumed tapered canal seizers. 
canal, with a long nose tip, followed by one liter of bacitracin 
solution (33,000 units per liter) in each canal. Subsequently, the 
entire soft tissue envelope and bony surfaces were irrigated with 
six liters of saline solution, followed by two liters of bacitracin 
solution. 
  To conserve surgical time, we simultaneously fabricated 
the cement-tapered stems on the back table. Our specialized 
stem mold (Fig. 2) was used to produce the antibiotic canal 
spacers. Our protocol includes 80 grams (two packs) of 
polymethylmethacrylate cement (Simplex P; Stryker, 
Mahwah, NJ), premixed with 1 gram of tobramycin per 40 
grams of cement. To this we added 4.8 grams of tobramycin 
powder, and 2 grams of vancomycin powder for a total of4.4 
grams of antibiotics per 40 grams of cement powder. For 
mixing we added a third bottle of monomer due to the added 
volume of the antibiotics. The cement was mixed and poured 
into the appropriate size tapered stem molds (Fig. 3). A large 
threaded Steinmann pin was placed into each cement mold 
leaving 2 inches protruding beyond the mold (Fig. 4). After 
full polymerization of the cement, the mold is split and the 
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Fig. (3). Antibiotic cement being pored into the costume mold for 
preparation of an antibiotic spacer. 
 
Fig. (4). Costume cement spacers curing in the costume mold with 
Schanz pins inserted as a rebar for spacer strengthening. 
stems are removed (Fig. 5). The stems were placed 
appropriately in the femoral and tibial canals, any excess 
length of the Steinmann pins was trimmed with a bolt cutter, 
and the overlapping pins were linked together with an 18-
gauge cerclage wire (Fig. 6). The leg was placed in nearly 
full extension, with physiologic external rotation of the tibia. 
Three packs of 40 grams of polymethylmethacrylate each 
 
 
Fig. (5). Prepared costume molded cement spacers for the femur 
and tibia canals. 
 
Fig. (6). Canal cement spacers placed in the femur and tibia and 
secured with 18 gage wires. 
with premixed 0.5 grams of gentamycin (Palacos R+G; 
Zimmer, Warsaw, IN) were mixed with 7.2 grams of 
tobramycin powder, and 3 grams of vancomycin powder for 
a total of 3.9 grams of antibiotics per 40 grams of cement 
powder. For mixing we added a fourth bottle of monomer 
due to the added volume of the antibiotics. The cement was 
injected into the space created between the distal femur and 
the proximal tibia overlaying the Steinmann pins (Fig. 7). At 
this point, during polymerization of the cement, the 
tourniquet was deflated (Fig. 8). 
 
Fig. (7). Antibiotic cement added to the knee joint to serve as an 
intraarticular spacer. 
 
Fig. (8). Tourniquet is deflated while the antibiotic cement spacer is 
hardening. Treatment Failure Among Infected Periprosthetic Patients  The Open Orthopaedics Journal, 2013, Volume 7    267 
  Patients were allowed to fully weight bear on the 
operated leg with bilateral upper extremity support as long as 
the knee immobilizer was in place (Fig. 9). Patients received 
culture specific intravenous antibiotic treatment for a period 
of at least 6 weeks under the supervision of an infectious 
diseases specialist. Patients were followed with serial 
inflammation markers, CRP and ESR, during this period. 
Repeat arthrocentesis was done to monitor cell count and 
cultures after an antibiotic free period of at least 2 weeks. 
Surgical wound was monitored during office visits at 2 
weeks and 6 weeks post operatively, and 1 week prior to the 
planned 2
nd stage reimplantation surgery. Patients were 
monitored for complications related to the procedure and 
treatment. 
 
Fig. (9). Anteroposterior X-ray of the intraarticular antibiotic 
cement spacer and costume molded canal spacers. 
  Reimplantation was considered between 3-4 months after 
the initial procedure if the knee joint aspiration had a 
negative culture and low cell counts, as well a descending 
trend of inflammatory markers. Revision surgery was 
completed with Palacos R+G bone cement (Palacos R+G; 
Zimmer, Warsaw, IN), and intraoperative tissue and fluid 
cultures were taken. 
  We defined “successful two stage revision” if no further 
surgical procedures were conducted during the follow up 
period (e.g. irrigation and debridement, explant, fusion, 
amputation, revision TKA for non infectious etiology); this 
was our primary outcome. We defined “eradication of 
infection” if intraoperative cultures at the time of revision 
surgery were negative and if the patient had no further 
infection related procedure in the following year; this was 
our secondary outcome. 
Data Analysis 
  Categorical variables were analyzed using chi-square test 
and Fisher’s exact test. Continuous variables were analyzed 
using the t-test and Wilcoxon test. All analyses were 
conducted using SAS software, version 9.1.3 (SAS Institute, 
Carey, NC). 
 
RESULTS 
  Our study cohort consisted of 84 patients who were 
treated by a two-stage TKA revision for periprosthetic 
infection. Six patients died and three patients were lost to 
follow up prior to completing the 2
nd stage procedure. 75 
patients were included in the final analysis, with a mean age 
of 67.3 ±12.0 (range 41.4-90.1), 38 males (50.7%), and 37 
females (49.3%). Average BMI was 33.2 kg/m
2 (range 22.6-
59.1). A Charlson comorbidities index of 0 or 1 was found in 
48% of the patients, 52% had an index of 2 or more. The 
median length of time between the patient’s primary TKA 
surgery and the first stage revision surgery was 3.1 years 
(range: 1 week - 26 years). Sixty of these patients (82%) had 
more than one surgery on the infected total knee before 
antibiotic spacer placement. Out of these twenty-two had 2 
surgeries prior to antibiotic spacer placement, nineteen had 
3, and nineteen had 4 or more surgeries prior to the first 
stage revision and antibiotic spacer placement at our 
institution. Two patients had undergone preliminary cement 
spacer at an outside institution (all of them underwent a 
repeat 1
st stage procedure at our institution). 
  Only 38 of the 75 patients had complete preoperative 
cultures compared to 67 with complete intraoperative 
cultures. Staphylococcus species predominated as the 
organism responsible for the infections, with 34.3% of the 
preoperative cultures positive for Staphylococcus species 
(MSSA 21.1%, and MRSA 13.2%), and 41.8% of the 
intraoperative cultures positive for Staphylococcus species 
(MSSA 25.4%, and MRSA 16.4%) (Table 1). 
Table  1.  Knee Joint Fluid Culture Results Taken in Clinic 
Before the Patient Underwent Explant and 
Antibiotic Spacer Placement and During the 
Procedure Itself 
 
Preoperative  
Culture 
N=38 
Intraoperative  
Culture 
N=67  Microorganism 
N (%)  N (%) 
E. coli  4 (10.5%)  2 (3.0%) 
Enterococcus  3 (7.9%)  4 (6.0%) 
MSSA  8 (21.1%)  16 (23.9%) 
MRSA  5 (13.2%)  11 (16.4%) 
Streptococcus (other)  4 (10.5%)  6 (9.0%) 
Micrococcus 0  1  (1.5%) 
Corynebacterium 0 3  (4.5%) 
Peptostreptococcus magnus  0 1  (1.5%) 
E.coli/MSSA/P.mirabilis 0  1  (1.5%) 
Other 3  (7.9%)  0 
No growth  11 (29.0%)  22 (32.8%) 
Missing  37 (--)  8  (--) 
 
  Joint fluid analysis revealed a median WBC count of 
25,650 cells/mcL (range 43-366,000) preoperatively, and 
21,400 cells/mcL (range 9-132,000) intraoperatively during 
the first stage procedure. Prior to reimplantation median 268    The Open Orthopaedics Journal, 2013, Volume 7  Schwarzkopf et al. 
CRP values were 11.8 mm/hr and median ESR values were 
50 mg/dL. 
  Patients’ average range of motion in the most recent 
follow up visit was -2.1 (range: 0 - -15) degrees of extension 
to 88.7 (range: 0-120) degrees of flexion. Thirty-two 
(65.3%) of the 49 patients with gait evaluation had a normal 
gait (evaluated on clinical exam) during their last follow up 
visit. At final radiographic follow up, none of the 
reimplanted components were radiographically loose. 
  After a mean follow up of 25.1 months (range 12 month 
to 108 months), a successful 2
nd stage revision procedure 
was performed on 70.7% of the patients with 5 patients 
needing continuous antibiotic suppression treatment. 
Eradication of the infection was documented in 90.7% of the 
patients, and the presenting infection was eradicated and a 
successful 2
nd stage was completed in 64.0% of patients 
(Table  2). Out of the 75 patient cohort 53 patients had a 
successful 2
nd stage reimplantation, 19 underwent further 
fusion, and 3 underwent amputation as the final surgical 
outcome (Flow Chart). Criteria for fusion included 
continued infection as well as compromised extensor 
mechanism and poor patient medical condition (“Fragile 
host”). Patients that had an unacceptable risk of persistent 
infection and poor soft tissue coverage as well as patients 
that were not candidates of extensor mechanism allograft 
were offered a knee fusion. 
  Twelve patients had become reinfected after the two-
stage revision; reinfection was documented at an average of 
14.6 months after the 2
nd stage reimplantation procedure. 
Eight of the patients had the same organism cultured as in 
the first infection, and 5 patients were infected with a new 
organism. Six patients were managed with vancomycin, 3 
patients were managed with cefazolin, 1 patient with 
nafcillin, 1 patient with linezolid, and 1 patient with 
penicillin. Out of the 12 patients that were reinfected, 5 were 
treated with suppression antibiotics, 4 underwent fusion after 
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a subsequent period of antibiotic spacer placement, and 3 
underwent amputation after failed attempts of limb salvage. 
Table  2.  Patients’ Outcomes Among Three End Points: 
Successful 2-Stage Revision, Eradication of 
Infection, and Achieving Both a Successful 2-Stage 
Revision and Eradication of Infection 
 
Outcome  (N=75)  Frequency  
(N, %) 
95%  
CI 
2-stage reimplantation  53 (70.7%)  58.5 - 82.9 
Eradication of infection   68 (90.7%)  83.9 - 97.5 
2-stage reimplantation +  
infection eradication  
48 (64.0%)  48.7 - 79.3 
 
  Out of 75 patients, 8 had a history of a prior infected total 
joint replacement (in shoulder, hip, or contralateral knee); of 
these 8 patients, 3 had fusion. Of the 19 patients that 
underwent knee fusion, 12 were done due to persistent 
infection and 7 due to extensor mechanism failure in light of 
previous infection and previous multiple surgeries done in 
outside hospitals prior to presentation to our center (Table 3). 
Table  3.  Association Between Patient Variables, and a 
Successful 2
nd Stage Outcome 
 
2
nd Stage Success  
(N=53) 
2
nd Stage Failure  
(N=22)  Variable 
N (%)  N (%) 
p-Value 
Sex 
Male 
Female 
 
28 (52.8) 
25 (47.2) 
 
10 (45.5) 
12 (54.6) 
.56 
Charlson Score 
0-1 
 2 
 
28 (52.8) 
25 (47.2) 
 
8 (36.4) 
14 (63.6) 
.19 
OR culture* 
None/other 
MSSA/MRSA 
 
29 (60.4) 
19 (39.6) 
 
10 (52.6) 
9 (47.4) 
.56 
OR culture* 
None/other 
MRSA 
 
41 (85.4) 
7 (14.6) 
 
15 (79.0) 
4 (21.1) 
.49 
Secondary surgery  
prior to explant 
No 
Yes 
 
 
30 (56.6) 
23 (43.4) 
 
 
8 (36.4) 
14 (63.6) 
.11 
Other infected 
joints 
No 
Yes 
 
 
48 (90.6) 
5 (9.4) 
 
 
19 (86.4) 
3 (13.6) 
.69 
* < 75 due to missing data. 
 
  We found no statistically significant association between 
successful 2
nd stage reimplantation and patient Charlson 
comorbidities index (p=0.19) (Table 3). A trend was noted 
when we examined the association between the pre-
reimplantation levels of ESR and CRP (p=0.09, p=0.06 
respectively), and the chance of a successful 2
nd stage 
reimplantation (Table 4). 
  We found a suggestion of an association between any 
surgical procedure prior to the 1
st stage procedure and a 
successful 2
nd stage procedure with eradication of the 
infection (Table 3). Although not reaching statistical 
significance, those without any prior procedures appeared 
more likely to have a successful outcome with eradication of 
infection (p=.08). Of those without a prior surgical 
procedure, 28/38 (74%) had a successful outcome with 
infection eradication, as contrasted with 20/37 (54%) of 
those with a prior surgical procedure. In addition, there was a 
suggestion that those who had a MRSA (resistant 
staphylococcus) infection were less likely to show infection 
eradication (p=.05). 
DISCUSSION 
  Periprosthetic infection after total knee arthroplasty is a 
devastating complication that increases morbidity for the 
patient and cost to the medical system. Today, two-stage 
revision surgery is regarded as the appropriate treatment 
protocol for chronic periprosthetic infections after TKA. The 
ultimate goal of two-stage revision surgery is to achieve a 
lasting eradication of the infection and a durable TKA 
reconstruction. Eradication of the infection is achieved by 
implant extraction, debridement and irrigation of the tissues, 
elution of antibiotics from the polymethylmethacrylate 
spacer, and systemic, microorganism specific, intravenous 
antibiotics. 
  Our study had a few limitations. First we had a relatively 
small number of patients included in the cohort. Second, due 
to the small sample size of our study, we were unable to 
construct a more complex analyses model to examine the 
multitude of variables among our patients, especially the 
influence of medical comorbidities. Despite these limitations 
our study represents a consecutive single surgeon experience 
with two-stage revision surgery for complicated chronic 
TKA periprosthetic infection using a single treatment 
protocol, with most of the patients 82% undergoing multiple 
surgeries prior to presentation. 
  Many studies have shown the value of joint fluid analysis 
for the initial diagnosis of periprosthetic infection [23-25], 
but few have reported about the predictive value of joint 
fluid characteristics on the reinfection rate and failure of the 
two-stage revision surgery [24, 26, 27]. Both Ghanem et al. 
in a study with 109 patients, and Kusuma et al. with 76 
patients, did not show any predictive value for ESR and CRP 
lab values taken between the first and second stage 
procedure in predicting persistent infection [26, 27]. This is 
in line with the results presented by Mortazavi et al. where 
ESR and CRP were not predictive for the outcome of PJI 
revisions [28]. However, the study by Mortazai et al. 
attributes this to a possible Type II error. Although all the 
above studies showed a decrease in both values between the 
first and second stage procedure in cases where the infection 
was controlled. In our study we similarly observed a 
decrease in the levels of ESR and CRP between the first and 
second stage procedure. We were unable to recommend any 
cutoff levels due to the small number of patients in our 
study. In order to achieve significance, a multicenter effort to 270    The Open Orthopaedics Journal, 2013, Volume 7  Schwarzkopf et al. 
create a large patient cohort with comparable treatment 
protocols is needed in order to achieve these results. 
  The utility of joint fluid cultures obtained prior to 
reimplantation is still debated in the literature. Ghanem et al. 
reported a high incidence of both false positive and false 
negative results. However they still recommended obtaining 
joint fluid cultures prior to second stage reimplantation [27]. 
Lonner et al. reported that joint fluid cultures taken prior to 
the second stage reimplantation were not useful in predicting 
persistent infection [23]. In contrast a study by Kurd et al. 
reported that patients who failed two-stage revision were 
3.37 times more likely to have a positive culture for 
methicillin-resistant bacteria [29]. Tigani et al. reported in 
their study that in the face of positive intraoperative cultures 
recurrence of infection was 83% compared to 12.5% with 
negative intraoperative cultures [30]. Similarly, we observed 
a higher rate of successful two-stage revision in the absence 
of methicillin-resistant staphylococcus infection. 
  Patients who undergo an irrigation and debridement 
procedure prior to a two-stage revision have been shown to 
have a higher failure rate as demonstrated by Sherrell et al. 
[31]. In their study 34% of the patients who had a previous 
irrigation and debridement procedure failed a two-stage 
revision procedure for TKA periprosthetic infection. These 
data concur with our finding suggesting that patients who 
had undergone pre-revision surgical procedures had a lower 
likelihood of a successful two-stage revision. 
  The higher failure rate of two-stage revision observed in 
our series may be attributed to the highly specialized referral 
practice of the senior author, which draws patients that had 
failed prior interventions for failed and infected TKA as well 
as poor patient characteristics (“fragile host”). The high rate 
of knee fusion seen in our cohort can be attributed to the 
high number of previous surgeries and the condition of the 
knee and extensor mechanism among our patients upon 
presentation to our center. Factors affecting the high failure 
rate may include previous surgical treatment for PJI, 82% of 
the cohort had multiple surgeries prior to the two-stage 
revision done at our institution, and high prevalence of 
MRSA present among failed cases. 
  Future research in the field should be aimed at finding 
better diagnostic tools to aid us in our decision process when 
considering reimplantation for chronic periprosthetic 
infection. 
CONCLUSION 
  Patients infected by the staphylococcus organism, and 
those who have undergone multiple procedures prior to the 
two-stage revision may have a lower rate of a successful 
two-stage revision with eradication of the infection. 
CONFLICT OF INTEREST 
  The authors confirm that this article content has no 
conflict of interest. 
ACKNOWLEDGEMENTS 
 Declared  none. 
GRANT SUPPORT 
•  Program for Research Incubation and Development, 
Dept Orthopedics, BWH. 
•  NIH P60 AR 47782. 
REFERENCES 
[1]  Kelly MA, Clarke HD. Long-term results of posterior cruciate 
substituting total knee arthroplasty. Clin Orthop Relat Res 2002; 
404: 51-7. 
[2]  Konig A, Kirschner S. Long-term results in total knee arthroplasty 
[in German]. Orthopade 2003; 32: 516-26. 
[3]  Ranawat CS, Flynn WF, Saddler S, Hansraj KK, Maynard MJ. 
Long-term results of the total condylar knee arthroplasty. A 15-year 
survivorship study. Clin Orthop Relat Res 1993; 286: 94-102. 
[4]  Gill GS, Joshi AB. Long-term results of cemented, posterior 
cruciate ligament-retaining total knee arthroplasty in osteoarthritis. 
Am J Knee Surg 2001; 14: 209-14. 
[5]  Rand JA, Fitzgerald RH. Diagnosis and management of the 
infected total knee arthroplasty. Orthop Clin North Am 1989; 20: 
201-10. 
[6]  Spangehl MJ, Hanssen AD. Management of the infected total knee 
replacement. Curr Opin Orthop 2002; 13: 23-9. 
[7]  Wilson MG, Kelley K, Thornhill TS. Infection as a complication of 
total knee-replacement arthroplasty. Risk factors and treatment in 
sixty-seven cases. J Bone Joint Surg Am 1990; 72: 878-83. 
[8]  Salvati EA, Robinson RP, Zeno SM, et al. Infection rates after 
3175 total hip and total knee replacements performed with and 
without a horizontal unidirectional filtered air-flow system. J Bone 
Joint Surg Am 1982; 64: 525. 
[9]  Booth RE Jr, Lotke PA. The results of spacer block technique in 
revision of infected total knee arthroplasty. Clin Orthop Relat Res 
1989; 248: 57-60. 
[10]  Wilde AH, Ruth JT. Two-stage reimplantation in infected total 
knee arthroplasty. Clin Orthop Relat Res 1988; 236: 23-35. 
[11]  Insall JN, Thompson FM, Brause BD. Two-stage reimplantation 
for the salvage of infected total knee arthroplasty. J Bone Joint 
Surg Am 1983; 65: 1087-98. 
Table 4.  Association Between Patients’ age, BMI, and Joint Fluid Markers, with 2
nd Stage Revision Outcome 
 
2
nd Stage Success  2
nd Stage Failure 
Variable 
N Median  (Range) N  Median  (Range) 
p-Value 
Age  53 67.8  (41.4-90.1) 22  69.9  (43.5-85.7)  .50* 
BMI  27 30.7  (22.6-48.9) 17  33.7  (23.5-59.1)  .33** 
ESR at reimplantation  48 47.5  (4.0-124.0) 19 64.0  (13.0-107.0)  .09** 
CRP at reimplantation  50 11.0  (0.4-251.0) 19  14.8  (1.0-193.1)  .06** 
WBC at reimplantation  41  19,000 (9-132,000)  12  25,600 (260-99,600)  .37** 
PMN (%) at reimplantation  41 86  (2-99) 12  91.5  (16-96)  .27** 
*t-test.  
**Wilcoxon test. Treatment Failure Among Infected Periprosthetic Patients  The Open Orthopaedics Journal, 2013, Volume 7    271 
[12]  Goldman RT, Scuderi GR, Insall JN. 2-stage reimplantation for 
infected total knee replacement. Clin Orthop Relat Res 1996; 331: 
118-24. 
[13]  Jacobs MA, Hungerford DS, Krackow KA, Lennox DW. Revision 
of septic total knee arthroplasty. Clin Orthop Relat Res 1989; 238: 
159-66. 
[14]  Teeny SM, Dorr L, Murata G, Conaty P. Treatment of infected 
total knee arthroplasty. Irrigation and debridement versus two stage 
reimplantation. J Arthroplasty 1990; 5: 35-9. 
[15]  Cohen JC, Hozack WJ, Cucker JM, et al. Two-stage reimplantation 
of septic total knee arthroplasty. Report of three cases using an 
antibiotic-PMMA spacer block. J Arthroplasty 1988; 3: 369. 
[16]  Wan Z, Karim A, Incavo SJ, Mathis KB. Preformed Articulating 
Knee Spacers in 2-Stage Total Knee Revision Arthroplasty: 
Minimum 2-Year Follow-Up. J Arthroplasty 2012; 27(8): 1469-73. 
[17]  Van Thiel GS, Berend KR, Klein GR, Gordon AC, Lombardi AV, 
Della Valle CJ. Intraoperative molds to create an articulating spacer 
for the infected knee arthroplasty. Clin Orthop Relat Res 2011; 
469(4): 994-1001. 
[18]  Gooding CR, Masri BA, Duncan CP, Greidanus NV, Garbuz DS. 
Durable infection control and function with the PROSTALAC 
spacer in two-stage revision for infected knee arthroplasty. Clin 
Orthop Relat Res 2011; 469(4): 985-93. 
[19]  Emerson RH Jr, Muncie M, Tarbox TR, Higgins LL. Comparison 
of a static with a mobile spacer in total knee infection. Clin Orthop 
Relat Res 2002; 404: 132-8. 
[20]  Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus 
static spacers in revision total knee arthroplasty for sepsis. The 
Ranawat Award. Clin Orthop Relat Res 2000; 380: 9-16. 
[21]  Huang HT, Su JY, Chen SK. The results of articulating spacer 
technique for infected total knee arthroplasty. J Arthroplasty 2006; 
21: 1163-8. 
[22]  Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method 
of classifying prognostic comorbidity in longitudinal studies: 
development and validation. J Chronic Dis 1987; 40(5): 373-83. 
[23]  Lonner JH, Siliski JM, Della Valle C, DiCesare P, Lotke PA. Role 
of knee aspiration after resection of the infected total knee 
arthroplasty. Am J Orthop 2001; 30: 305-9. 
[24]  Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg 
JM, Patel R. Synovial fluid leukocyte count and differential for the 
diagnosis of prosthetic knee infection. Am J Med 2004; 117: 556-
62. 
[25]  Della Valle CJ, Sporer SM, Jacobs JJ, Berger RA, Rosenberg AG, 
Paprosky WG. Preoperative testing for sepsis before revision total 
knee arthroplasty. J Arthroplasty 2007; 22(6 Suppl 2): 90-3. 
[26]  Kusuma SK, Ward J, Jacofsky M, Sporer SM, Della Valle CJ. 
What is the role of serological testing between stages of two-stage 
reconstruction of the infected prosthetic knee? Clin Orthop Relat 
Res 2011; 469(4): 1002-8. 
[27]  Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision 
for knee arthroplasty infection: what is the role of serologic tests 
before reimplantation? Clin Orthop Relat Res 2009; 467: 1699-705. 
[28]  Mortazavi SM, Vegari D, Ho A, Zmistowski B, Parvizi J. Two-
stage exchange arthroplasty for infected total knee arthroplasty: 
predictors of failure. Clin Orthop Relat Res 2011; 469(11): 3049-
54. 
[29]  Kurd MF, Ghanem E, Steinbrecher J, Parvizi J. Two-stage 
exchange knee arthroplasty: does resistance of the infecting 
organism influence the outcome? Clin Orthop 2010; 468: 2060-6. 
[30]  Tigani D, Trisolino G, Fosco M, Ben Ayad R, Costigliola P. Two-
stage reimplantation for periprosthetic knee infection: Influence of 
host health status and infecting microorganism. Knee 2013; 20(1): 
9-18. 
[31]  Sherrell JC, Fehring TK, Odum S, et al. Periprosthetic Infection 
Consortium. The Chitranjan Ranawat Award: fate of two-stage 
reimplantation after failed irrigation and débridement for 
periprosthetic knee infection. Clin Orthop Relat Res 2011; 469(1): 
18-25. 
 
 
Received: January 7, 2013  Revised: April 13, 2013  Accepted: April 20, 2013 
 
© Schwarzkopf et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 
which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 
 
 